Showing results (81-90 of 745) with videos related to

Sort By:
Pageof 75
The Journal of Antimicrobial Chemotherapy|June 28, 2020
The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeuticsMarco Siccardi, Jonathan Schapiro, Giovanni Di Perri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 20, 2011
IFN-γ 874A>T genotype is associated with higher CCR5 expression in peripheral blood mononuclear cells from HIV+ patientsNeill J Liptrott, Deirdre Egan, David J Back, et al.
European Journal of Clinical Pharmacology|January 1, 1988
A comparison of the pharmacokinetics of mefloquine in healthy Thai volunteers and in Thai patients with falciparum malariaJ Karbwang, D J Back, D Bunnag, et al.
Bulletin of the World Health Organization|January 1, 1990
Pharmacokinetics of mefloquine in combination with sulfadoxine-pyrimethamine and primaquine in male Thai patients with falciparum malariaJ Karbwang, D J Back, D Bunnag, et al.
Antiviral Therapy|November 13, 2004
Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNAAndrew Owen, Becky Chandler, Dave J Back, et al.
The Journal of Antimicrobial Chemotherapy|March 22, 2013
Predicting intestinal absorption of raltegravir using a population-based ADME simulationDarren M Moss, Marco Siccardi, David J Back, et al.
Pharmacogenetics and Genomics|June 14, 2013
RXRγ gene variants are associated with HIV lipodystrophySudeep P Pushpakom, Andrew Owen, David J Back, et al.
Antiviral Therapy|December 14, 2011
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tractLaura J Else, Stephen Taylor, David J Back, et al.
International Journal of STD & AIDS|March 4, 2009
The impact of pharmacogenetics on HIV therapyT W Mahungu, M A Johnson, A Owen, et al.
Pageof 75